Director, Technical Accounting and SEC Reporting

Stoke Therapeutics•Bedford, MA

7h•$220,000 - $247,000•Hybrid

About The Position

Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ We are seeking a Director, Technical Accounting and SEC Reporting. In this newly created position, which reports to the Vice President, Controller, you will oversee all aspects of the Company’s technical accounting, SOX controls and external reporting activities within a publicly traded environment. This position ensures full compliance with U.S. GAAP and SEC regulations, leads the preparation and filing of all SEC reports, and provides authoritative guidance on complex accounting matters. The Director serves as a key advisor to executive leadership and plays a critical role in maintaining the integrity, transparency, and accuracy of the Company’s financial disclosures to investors, regulators, and external stakeholders.

Requirements

Bachelor’s degree in Accounting or related field required; CPA required
10+ years of progressive accounting experience
Significant experience in Big Four public accounting or a large regional firm and/or public company environment
Extensive hands-on experience with SEC reporting for a publicly traded company
Deep expertise in U.S. GAAP and SEC reporting regulations (Reg S-X, Reg S-K)
Strong experience with public company filing requirements and disclosure standards
Experience managing SOX (Sarbanes-Oxley) compliance programs
Proficiency with financial reporting systems (e.g., ActiveDisclosure, NetSuite)
Exceptional written communication skills, particularly in drafting financial disclosures
Proven ability to manage multiple deadlines in a highly regulated, fast-paced environment
Strong analytical mindset and attention to detail
Advanced Excel and financial analysis capabilities

Nice To Haves

Life sciences/biotech industry experience a plus

Responsibilities

Act as the Company’s subject matter expert on U.S. GAAP and SEC regulations
Lead the accounting analysis of complex, non-routine, and material transactions
Monitor FASB, SEC, and PCAOB developments and lead adoption and implementation of new standards
Work with external consultants and advisors in preparing technical accounting memos
Provide technical guidance to senior leadership and cross-functional partners
Oversee preparation, review, and timely filing of all SEC reports
Ensure accuracy and completeness of financial statements and footnotes, MD&A disclosures and earnings releases and supplemental materials
Maintain compliance with SEC rules, Reg S-X, Reg S-K, and other disclosure requirements
Evaluate emerging SEC disclosure trends and proactively enhance disclosures
Serve as the primary liaison with external auditors on technical accounting and SEC reporting matters
Prepare the Company for SOX 404B compliance related to financial reporting and disclosure controls
Ensure the design, documentation, and operating effectiveness of key controls
Partner with Internal Audit to address deficiencies and remediation plans
Drive continuous improvement in control processes and documentation